This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Istituto Di Ricerca Pediatrica Citta Della Speranza, Universitá Degli Studi Di Padova. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 43 
Years Active: 2025
Title: Martina Pigazzi: Innovator in Cancer Treatment
Introduction
Martina Pigazzi is a notable inventor based in Padua, Italy. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. Her work focuses on addressing critical medical challenges, particularly in pediatric oncology.
Latest Patents
Martina Pigazzi holds a patent for "Thioridazine derivatives and their use for the treatment of cancer." This invention relates to novel thioridazine analogue compounds that are particularly suitable for treating pediatric acute myeloid leukemia harboring the t(6;11)(q27;q23) KMT2A/AFDN rearrangement. This patent highlights her commitment to advancing therapeutic options for vulnerable patient populations.
Career Highlights
Throughout her career, Martina has been associated with prestigious institutions such as Università Degli Studi Di Padova and Istituto Di Ricerca Pediatrica Città Della Speranza. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Martina has worked alongside esteemed colleagues, including Claudia Tregnago and Romeo Romagnoli. These collaborations have enriched her research and expanded the impact of her innovations in cancer treatment.
Conclusion
Martina Pigazzi's contributions to cancer treatment through her innovative patents and collaborations underscore her role as a leading inventor in the medical field. Her dedication to improving therapeutic options for pediatric patients is commendable and highlights the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile